Latest News and Press Releases
Want to stay updated on the latest news?
-
PISCATAWAY, N.J., March 20, 2026 (GLOBE NEWSWIRE) -- BHAV Acquisition Corp (the “Company” or “BHAV”) today announced the closing of its previously announced initial public offering of 10,000,000...
-
NOVATO, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
-
BOSTON, March 20, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare...
-
Cheetah Net Supply Chain Service Inc. Announces Full Year 2025 Results and Provides Corporate Update
IRVINE, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- Cheetah Net Supply Chain Service Inc. (“Cheetah” or the “Company”) (Nasdaq CM: CTNT), a logistics and warehousing services provider, today reported...
-
RAMAT GAN, ISRAEL, March 20, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it plans to change the ratio of its...
-
TORONTO, Ontario and NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX: BITF) (“Bitfarms” or the “Company”), a North American digital infrastructure and energy company, today...
-
March 20, 2026 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases,...
-
PALO ALTO, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic...
-
Rocket Lab successfully launches its 84th mission, deploying an Earth observation satellite to orbit for Japanese customer
-
Sanuwave Will Host a Conference Call on March 27, 2025 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results